OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
March 18, 2019
The longstanding adherence problem is yielding to new technology
November 09, 2018
The widening scope of RWE data available from patients is changing both clinical and post-approval practices for drug development
May 17, 2017
An ‘overwhelming’ information load is affecting oncology’s ability to develop successful treatment pathways
November 07, 2016
The ‘age in place’ trend creates challenges for market access to seniors
September 01, 2016
Existing incentives continue to draw in new drug developers; payers begin to look at competitive markets to drive down drug costs
July 07, 2016
The scale of the cardiovascular market pushes payers to demand quality outcomes data